Diverse mechanisms of antiepileptic drugs in the development pipeline
To access this article, please choose from the options below
PII: S0920-1211(06)00063-5
doi:10.1016/j.eplepsyres.2006.02.004
© 2006 Elsevier B.V. All rights reserved.
PII: S0920-1211(06)00063-5
doi:10.1016/j.eplepsyres.2006.02.004
© 2006 Elsevier B.V. All rights reserved.